1. Home
  2. MDXH vs SRL Comparison

MDXH vs SRL Comparison

Compare MDXH & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • SRL
  • Stock Information
  • Founded
  • MDXH 2003
  • SRL 2017
  • Country
  • MDXH Belgium
  • SRL China
  • Employees
  • MDXH N/A
  • SRL N/A
  • Industry
  • MDXH
  • SRL Professional Services
  • Sector
  • MDXH
  • SRL Consumer Discretionary
  • Exchange
  • MDXH Nasdaq
  • SRL Nasdaq
  • Market Cap
  • MDXH 84.6M
  • SRL 88.5M
  • IPO Year
  • MDXH 2021
  • SRL N/A
  • Fundamental
  • Price
  • MDXH $2.18
  • SRL $5.81
  • Analyst Decision
  • MDXH Buy
  • SRL
  • Analyst Count
  • MDXH 1
  • SRL 0
  • Target Price
  • MDXH $6.00
  • SRL N/A
  • AVG Volume (30 Days)
  • MDXH 67.5K
  • SRL 3.3K
  • Earning Date
  • MDXH 08-20-2025
  • SRL 07-07-2025
  • Dividend Yield
  • MDXH N/A
  • SRL 17.93%
  • EPS Growth
  • MDXH N/A
  • SRL N/A
  • EPS
  • MDXH N/A
  • SRL N/A
  • Revenue
  • MDXH $94,507,000.00
  • SRL $24,535,042.00
  • Revenue This Year
  • MDXH $23.51
  • SRL N/A
  • Revenue Next Year
  • MDXH $17.68
  • SRL N/A
  • P/E Ratio
  • MDXH N/A
  • SRL N/A
  • Revenue Growth
  • MDXH 25.46
  • SRL N/A
  • 52 Week Low
  • MDXH $1.35
  • SRL $5.70
  • 52 Week High
  • MDXH $3.50
  • SRL $9.99
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 58.07
  • SRL 29.20
  • Support Level
  • MDXH $2.13
  • SRL $5.70
  • Resistance Level
  • MDXH $2.32
  • SRL $6.15
  • Average True Range (ATR)
  • MDXH 0.12
  • SRL 0.21
  • MACD
  • MDXH 0.01
  • SRL 0.01
  • Stochastic Oscillator
  • MDXH 76.19
  • SRL 8.15

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: